Global Dong Quai  Market

Dong Quai  Comprehensive Study by Type (Liquid, Tablets, Capsules, Tinctures, Tea, Topical creams, Powders), Application (Allergies, Headache, Premenstrual syndrome, Menstrual cramps, Fibroids, Nasal, Sinus congestion, Rheumatoid arthritis), End User (Dietary Supplement, Pharmaceutical, Others) Players and Region - Global Market Outlook to 2028

Dong Quai  Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dong Quai 
Dong Quai is a herb rich in compounds with anti-inflammatory and immune-stimulating effects, it is said to aid in treating a host of issues, from allergies and constipation to high blood pressure and also used to treat menstrual cramps and menopausal symptoms such as hot flashes. Dong Quai in supplemental form as a pill or liquid extract. According to the study done, it showed that 39 per cent of the women who took a concentrated dosage of DongQuai twice daily reported an improvement in their abdominal pain and a normalizing of their menstrual cycle. Demand for the Dong Quai is booming across the globe as a growing preference for organic treatment to treat the several issues related to health.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Dong Quai  market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Amax NutraSource, Inc. (United States), Bio Botanica, Inc. (United States), Carrubba Inc. (United States), Organic Herb Inc. (China), Naturex Group (France), Xian Yuensun Biological Technology Co. Ltd.( United States) and Symrise Inc.( Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Dong Quai  market by Type (Liquid, Tablets, Capsules, Tinctures, Tea, Topical creams and Powders), Application (Allergies, Headache, Premenstrual syndrome, Menstrual cramps, Fibroids, Nasal, Sinus congestion and Rheumatoid arthritis) and Region.



On the basis of geography, the market of Dong Quai  has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Dietary Supplement will boost the Dong Quai  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Emerging demand for organic treatments

Market Growth Drivers:
The growing presence of a huge customer base for natural remedial food and beverage products across the globe is one of the major driving factors of the growth

Challenges:
Lack of awareness regarding the Dong Quai

Restraints:
The adverse effect of using Dong Quai such as Loss of appetite, bloating, Diarrhea others

Opportunities:
The increasing adoption of Dong Quai in developing regions such as India, China

Market Leaders and their expansionary development strategies
In August 2020, Menstrual health company De Lune has launched of two menstrual health products that combine the latest science with all-natural ingredients. Steady Mood and Cramp Aid establish a new age of period health by using the best clinical research to provide safe, healthy, and drug-free period relief.
In March 2023, Goli Nutrition has launched their new Women's PMS Relief Gummies, The brand, renowned for creating the world's first Apple Cider Vinegar Gummies, seeks to revolutionize relief for PMS-linked symptoms. Aligning with Goli's brand values, the PMS Relief Gummies are made with quality ingredients you can pronounce and will be a delicious addition to wellness routines.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Dong Quai  Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Liquid
  • Tablets
  • Capsules
  • Tinctures
  • Tea
  • Topical creams
  • Powders
By Application
  • Allergies
  • Headache
  • Premenstrual syndrome
  • Menstrual cramps
  • Fibroids
  • Nasal
  • Sinus congestion
  • Rheumatoid arthritis
By End User
  • Dietary Supplement
  • Pharmaceutical
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The growing presence of a huge customer base for natural remedial food and beverage products across the globe is one of the major driving factors of the growth
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness regarding the Dong Quai
    • 3.4. Market Trends
      • 3.4.1. Emerging demand for organic treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dong Quai , by Type, Application, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Dong Quai  (Value)
      • 5.2.1. Global Dong Quai  by: Type (Value)
        • 5.2.1.1. Liquid
        • 5.2.1.2. Tablets
        • 5.2.1.3. Capsules
        • 5.2.1.4. Tinctures
        • 5.2.1.5. Tea
        • 5.2.1.6. Topical creams
        • 5.2.1.7. Powders
      • 5.2.2. Global Dong Quai  by: Application (Value)
        • 5.2.2.1. Allergies
        • 5.2.2.2. Headache
        • 5.2.2.3. Premenstrual syndrome
        • 5.2.2.4. Menstrual cramps
        • 5.2.2.5. Fibroids
        • 5.2.2.6. Nasal
        • 5.2.2.7. Sinus congestion
        • 5.2.2.8. Rheumatoid arthritis
      • 5.2.3. Global Dong Quai  by: End User (Value)
        • 5.2.3.1. Dietary Supplement
        • 5.2.3.2. Pharmaceutical
        • 5.2.3.3. Others
      • 5.2.4. Global Dong Quai  Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Dong Quai  (Price)
      • 5.3.1. Global Dong Quai  by: Type (Price)
  • 6. Dong Quai : Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Amax NutraSource, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio Botanica, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Carrubba Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Organic Herb Inc. (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Naturex Group (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Xian Yuensun Biological Technology Co. Ltd.( United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Symrise Inc.( Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Dong Quai  Sale, by Type, Application, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Dong Quai  (Value)
      • 7.2.1. Global Dong Quai  by: Type (Value)
        • 7.2.1.1. Liquid
        • 7.2.1.2. Tablets
        • 7.2.1.3. Capsules
        • 7.2.1.4. Tinctures
        • 7.2.1.5. Tea
        • 7.2.1.6. Topical creams
        • 7.2.1.7. Powders
      • 7.2.2. Global Dong Quai  by: Application (Value)
        • 7.2.2.1. Allergies
        • 7.2.2.2. Headache
        • 7.2.2.3. Premenstrual syndrome
        • 7.2.2.4. Menstrual cramps
        • 7.2.2.5. Fibroids
        • 7.2.2.6. Nasal
        • 7.2.2.7. Sinus congestion
        • 7.2.2.8. Rheumatoid arthritis
      • 7.2.3. Global Dong Quai  by: End User (Value)
        • 7.2.3.1. Dietary Supplement
        • 7.2.3.2. Pharmaceutical
        • 7.2.3.3. Others
      • 7.2.4. Global Dong Quai  Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Dong Quai  (Price)
      • 7.3.1. Global Dong Quai  by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dong Quai : by Type(USD Million)
  • Table 2. Dong Quai  Liquid , by Region USD Million (2017-2022)
  • Table 3. Dong Quai  Tablets , by Region USD Million (2017-2022)
  • Table 4. Dong Quai  Capsules , by Region USD Million (2017-2022)
  • Table 5. Dong Quai  Tinctures , by Region USD Million (2017-2022)
  • Table 6. Dong Quai  Tea , by Region USD Million (2017-2022)
  • Table 7. Dong Quai  Topical creams , by Region USD Million (2017-2022)
  • Table 8. Dong Quai  Powders , by Region USD Million (2017-2022)
  • Table 9. Dong Quai : by Application(USD Million)
  • Table 10. Dong Quai  Allergies , by Region USD Million (2017-2022)
  • Table 11. Dong Quai  Headache , by Region USD Million (2017-2022)
  • Table 12. Dong Quai  Premenstrual syndrome , by Region USD Million (2017-2022)
  • Table 13. Dong Quai  Menstrual cramps , by Region USD Million (2017-2022)
  • Table 14. Dong Quai  Fibroids , by Region USD Million (2017-2022)
  • Table 15. Dong Quai  Nasal , by Region USD Million (2017-2022)
  • Table 16. Dong Quai  Sinus congestion , by Region USD Million (2017-2022)
  • Table 17. Dong Quai  Rheumatoid arthritis , by Region USD Million (2017-2022)
  • Table 18. Dong Quai : by End User(USD Million)
  • Table 19. Dong Quai  Dietary Supplement , by Region USD Million (2017-2022)
  • Table 20. Dong Quai  Pharmaceutical , by Region USD Million (2017-2022)
  • Table 21. Dong Quai  Others , by Region USD Million (2017-2022)
  • Table 22. South America Dong Quai , by Country USD Million (2017-2022)
  • Table 23. South America Dong Quai , by Type USD Million (2017-2022)
  • Table 24. South America Dong Quai , by Application USD Million (2017-2022)
  • Table 25. South America Dong Quai , by End User USD Million (2017-2022)
  • Table 26. Brazil Dong Quai , by Type USD Million (2017-2022)
  • Table 27. Brazil Dong Quai , by Application USD Million (2017-2022)
  • Table 28. Brazil Dong Quai , by End User USD Million (2017-2022)
  • Table 29. Argentina Dong Quai , by Type USD Million (2017-2022)
  • Table 30. Argentina Dong Quai , by Application USD Million (2017-2022)
  • Table 31. Argentina Dong Quai , by End User USD Million (2017-2022)
  • Table 32. Rest of South America Dong Quai , by Type USD Million (2017-2022)
  • Table 33. Rest of South America Dong Quai , by Application USD Million (2017-2022)
  • Table 34. Rest of South America Dong Quai , by End User USD Million (2017-2022)
  • Table 35. Asia Pacific Dong Quai , by Country USD Million (2017-2022)
  • Table 36. Asia Pacific Dong Quai , by Type USD Million (2017-2022)
  • Table 37. Asia Pacific Dong Quai , by Application USD Million (2017-2022)
  • Table 38. Asia Pacific Dong Quai , by End User USD Million (2017-2022)
  • Table 39. China Dong Quai , by Type USD Million (2017-2022)
  • Table 40. China Dong Quai , by Application USD Million (2017-2022)
  • Table 41. China Dong Quai , by End User USD Million (2017-2022)
  • Table 42. Japan Dong Quai , by Type USD Million (2017-2022)
  • Table 43. Japan Dong Quai , by Application USD Million (2017-2022)
  • Table 44. Japan Dong Quai , by End User USD Million (2017-2022)
  • Table 45. India Dong Quai , by Type USD Million (2017-2022)
  • Table 46. India Dong Quai , by Application USD Million (2017-2022)
  • Table 47. India Dong Quai , by End User USD Million (2017-2022)
  • Table 48. South Korea Dong Quai , by Type USD Million (2017-2022)
  • Table 49. South Korea Dong Quai , by Application USD Million (2017-2022)
  • Table 50. South Korea Dong Quai , by End User USD Million (2017-2022)
  • Table 51. Taiwan Dong Quai , by Type USD Million (2017-2022)
  • Table 52. Taiwan Dong Quai , by Application USD Million (2017-2022)
  • Table 53. Taiwan Dong Quai , by End User USD Million (2017-2022)
  • Table 54. Australia Dong Quai , by Type USD Million (2017-2022)
  • Table 55. Australia Dong Quai , by Application USD Million (2017-2022)
  • Table 56. Australia Dong Quai , by End User USD Million (2017-2022)
  • Table 57. Rest of Asia-Pacific Dong Quai , by Type USD Million (2017-2022)
  • Table 58. Rest of Asia-Pacific Dong Quai , by Application USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Dong Quai , by End User USD Million (2017-2022)
  • Table 60. Europe Dong Quai , by Country USD Million (2017-2022)
  • Table 61. Europe Dong Quai , by Type USD Million (2017-2022)
  • Table 62. Europe Dong Quai , by Application USD Million (2017-2022)
  • Table 63. Europe Dong Quai , by End User USD Million (2017-2022)
  • Table 64. Germany Dong Quai , by Type USD Million (2017-2022)
  • Table 65. Germany Dong Quai , by Application USD Million (2017-2022)
  • Table 66. Germany Dong Quai , by End User USD Million (2017-2022)
  • Table 67. France Dong Quai , by Type USD Million (2017-2022)
  • Table 68. France Dong Quai , by Application USD Million (2017-2022)
  • Table 69. France Dong Quai , by End User USD Million (2017-2022)
  • Table 70. Italy Dong Quai , by Type USD Million (2017-2022)
  • Table 71. Italy Dong Quai , by Application USD Million (2017-2022)
  • Table 72. Italy Dong Quai , by End User USD Million (2017-2022)
  • Table 73. United Kingdom Dong Quai , by Type USD Million (2017-2022)
  • Table 74. United Kingdom Dong Quai , by Application USD Million (2017-2022)
  • Table 75. United Kingdom Dong Quai , by End User USD Million (2017-2022)
  • Table 76. Netherlands Dong Quai , by Type USD Million (2017-2022)
  • Table 77. Netherlands Dong Quai , by Application USD Million (2017-2022)
  • Table 78. Netherlands Dong Quai , by End User USD Million (2017-2022)
  • Table 79. Rest of Europe Dong Quai , by Type USD Million (2017-2022)
  • Table 80. Rest of Europe Dong Quai , by Application USD Million (2017-2022)
  • Table 81. Rest of Europe Dong Quai , by End User USD Million (2017-2022)
  • Table 82. MEA Dong Quai , by Country USD Million (2017-2022)
  • Table 83. MEA Dong Quai , by Type USD Million (2017-2022)
  • Table 84. MEA Dong Quai , by Application USD Million (2017-2022)
  • Table 85. MEA Dong Quai , by End User USD Million (2017-2022)
  • Table 86. Middle East Dong Quai , by Type USD Million (2017-2022)
  • Table 87. Middle East Dong Quai , by Application USD Million (2017-2022)
  • Table 88. Middle East Dong Quai , by End User USD Million (2017-2022)
  • Table 89. Africa Dong Quai , by Type USD Million (2017-2022)
  • Table 90. Africa Dong Quai , by Application USD Million (2017-2022)
  • Table 91. Africa Dong Quai , by End User USD Million (2017-2022)
  • Table 92. North America Dong Quai , by Country USD Million (2017-2022)
  • Table 93. North America Dong Quai , by Type USD Million (2017-2022)
  • Table 94. North America Dong Quai , by Application USD Million (2017-2022)
  • Table 95. North America Dong Quai , by End User USD Million (2017-2022)
  • Table 96. United States Dong Quai , by Type USD Million (2017-2022)
  • Table 97. United States Dong Quai , by Application USD Million (2017-2022)
  • Table 98. United States Dong Quai , by End User USD Million (2017-2022)
  • Table 99. Canada Dong Quai , by Type USD Million (2017-2022)
  • Table 100. Canada Dong Quai , by Application USD Million (2017-2022)
  • Table 101. Canada Dong Quai , by End User USD Million (2017-2022)
  • Table 102. Mexico Dong Quai , by Type USD Million (2017-2022)
  • Table 103. Mexico Dong Quai , by Application USD Million (2017-2022)
  • Table 104. Mexico Dong Quai , by End User USD Million (2017-2022)
  • Table 105. Dong Quai : by Type(USD/Units)
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Dong Quai : by Type(USD Million)
  • Table 114. Dong Quai  Liquid , by Region USD Million (2023-2028)
  • Table 115. Dong Quai  Tablets , by Region USD Million (2023-2028)
  • Table 116. Dong Quai  Capsules , by Region USD Million (2023-2028)
  • Table 117. Dong Quai  Tinctures , by Region USD Million (2023-2028)
  • Table 118. Dong Quai  Tea , by Region USD Million (2023-2028)
  • Table 119. Dong Quai  Topical creams , by Region USD Million (2023-2028)
  • Table 120. Dong Quai  Powders , by Region USD Million (2023-2028)
  • Table 121. Dong Quai : by Application(USD Million)
  • Table 122. Dong Quai  Allergies , by Region USD Million (2023-2028)
  • Table 123. Dong Quai  Headache , by Region USD Million (2023-2028)
  • Table 124. Dong Quai  Premenstrual syndrome , by Region USD Million (2023-2028)
  • Table 125. Dong Quai  Menstrual cramps , by Region USD Million (2023-2028)
  • Table 126. Dong Quai  Fibroids , by Region USD Million (2023-2028)
  • Table 127. Dong Quai  Nasal , by Region USD Million (2023-2028)
  • Table 128. Dong Quai  Sinus congestion , by Region USD Million (2023-2028)
  • Table 129. Dong Quai  Rheumatoid arthritis , by Region USD Million (2023-2028)
  • Table 130. Dong Quai : by End User(USD Million)
  • Table 131. Dong Quai  Dietary Supplement , by Region USD Million (2023-2028)
  • Table 132. Dong Quai  Pharmaceutical , by Region USD Million (2023-2028)
  • Table 133. Dong Quai  Others , by Region USD Million (2023-2028)
  • Table 134. South America Dong Quai , by Country USD Million (2023-2028)
  • Table 135. South America Dong Quai , by Type USD Million (2023-2028)
  • Table 136. South America Dong Quai , by Application USD Million (2023-2028)
  • Table 137. South America Dong Quai , by End User USD Million (2023-2028)
  • Table 138. Brazil Dong Quai , by Type USD Million (2023-2028)
  • Table 139. Brazil Dong Quai , by Application USD Million (2023-2028)
  • Table 140. Brazil Dong Quai , by End User USD Million (2023-2028)
  • Table 141. Argentina Dong Quai , by Type USD Million (2023-2028)
  • Table 142. Argentina Dong Quai , by Application USD Million (2023-2028)
  • Table 143. Argentina Dong Quai , by End User USD Million (2023-2028)
  • Table 144. Rest of South America Dong Quai , by Type USD Million (2023-2028)
  • Table 145. Rest of South America Dong Quai , by Application USD Million (2023-2028)
  • Table 146. Rest of South America Dong Quai , by End User USD Million (2023-2028)
  • Table 147. Asia Pacific Dong Quai , by Country USD Million (2023-2028)
  • Table 148. Asia Pacific Dong Quai , by Type USD Million (2023-2028)
  • Table 149. Asia Pacific Dong Quai , by Application USD Million (2023-2028)
  • Table 150. Asia Pacific Dong Quai , by End User USD Million (2023-2028)
  • Table 151. China Dong Quai , by Type USD Million (2023-2028)
  • Table 152. China Dong Quai , by Application USD Million (2023-2028)
  • Table 153. China Dong Quai , by End User USD Million (2023-2028)
  • Table 154. Japan Dong Quai , by Type USD Million (2023-2028)
  • Table 155. Japan Dong Quai , by Application USD Million (2023-2028)
  • Table 156. Japan Dong Quai , by End User USD Million (2023-2028)
  • Table 157. India Dong Quai , by Type USD Million (2023-2028)
  • Table 158. India Dong Quai , by Application USD Million (2023-2028)
  • Table 159. India Dong Quai , by End User USD Million (2023-2028)
  • Table 160. South Korea Dong Quai , by Type USD Million (2023-2028)
  • Table 161. South Korea Dong Quai , by Application USD Million (2023-2028)
  • Table 162. South Korea Dong Quai , by End User USD Million (2023-2028)
  • Table 163. Taiwan Dong Quai , by Type USD Million (2023-2028)
  • Table 164. Taiwan Dong Quai , by Application USD Million (2023-2028)
  • Table 165. Taiwan Dong Quai , by End User USD Million (2023-2028)
  • Table 166. Australia Dong Quai , by Type USD Million (2023-2028)
  • Table 167. Australia Dong Quai , by Application USD Million (2023-2028)
  • Table 168. Australia Dong Quai , by End User USD Million (2023-2028)
  • Table 169. Rest of Asia-Pacific Dong Quai , by Type USD Million (2023-2028)
  • Table 170. Rest of Asia-Pacific Dong Quai , by Application USD Million (2023-2028)
  • Table 171. Rest of Asia-Pacific Dong Quai , by End User USD Million (2023-2028)
  • Table 172. Europe Dong Quai , by Country USD Million (2023-2028)
  • Table 173. Europe Dong Quai , by Type USD Million (2023-2028)
  • Table 174. Europe Dong Quai , by Application USD Million (2023-2028)
  • Table 175. Europe Dong Quai , by End User USD Million (2023-2028)
  • Table 176. Germany Dong Quai , by Type USD Million (2023-2028)
  • Table 177. Germany Dong Quai , by Application USD Million (2023-2028)
  • Table 178. Germany Dong Quai , by End User USD Million (2023-2028)
  • Table 179. France Dong Quai , by Type USD Million (2023-2028)
  • Table 180. France Dong Quai , by Application USD Million (2023-2028)
  • Table 181. France Dong Quai , by End User USD Million (2023-2028)
  • Table 182. Italy Dong Quai , by Type USD Million (2023-2028)
  • Table 183. Italy Dong Quai , by Application USD Million (2023-2028)
  • Table 184. Italy Dong Quai , by End User USD Million (2023-2028)
  • Table 185. United Kingdom Dong Quai , by Type USD Million (2023-2028)
  • Table 186. United Kingdom Dong Quai , by Application USD Million (2023-2028)
  • Table 187. United Kingdom Dong Quai , by End User USD Million (2023-2028)
  • Table 188. Netherlands Dong Quai , by Type USD Million (2023-2028)
  • Table 189. Netherlands Dong Quai , by Application USD Million (2023-2028)
  • Table 190. Netherlands Dong Quai , by End User USD Million (2023-2028)
  • Table 191. Rest of Europe Dong Quai , by Type USD Million (2023-2028)
  • Table 192. Rest of Europe Dong Quai , by Application USD Million (2023-2028)
  • Table 193. Rest of Europe Dong Quai , by End User USD Million (2023-2028)
  • Table 194. MEA Dong Quai , by Country USD Million (2023-2028)
  • Table 195. MEA Dong Quai , by Type USD Million (2023-2028)
  • Table 196. MEA Dong Quai , by Application USD Million (2023-2028)
  • Table 197. MEA Dong Quai , by End User USD Million (2023-2028)
  • Table 198. Middle East Dong Quai , by Type USD Million (2023-2028)
  • Table 199. Middle East Dong Quai , by Application USD Million (2023-2028)
  • Table 200. Middle East Dong Quai , by End User USD Million (2023-2028)
  • Table 201. Africa Dong Quai , by Type USD Million (2023-2028)
  • Table 202. Africa Dong Quai , by Application USD Million (2023-2028)
  • Table 203. Africa Dong Quai , by End User USD Million (2023-2028)
  • Table 204. North America Dong Quai , by Country USD Million (2023-2028)
  • Table 205. North America Dong Quai , by Type USD Million (2023-2028)
  • Table 206. North America Dong Quai , by Application USD Million (2023-2028)
  • Table 207. North America Dong Quai , by End User USD Million (2023-2028)
  • Table 208. United States Dong Quai , by Type USD Million (2023-2028)
  • Table 209. United States Dong Quai , by Application USD Million (2023-2028)
  • Table 210. United States Dong Quai , by End User USD Million (2023-2028)
  • Table 211. Canada Dong Quai , by Type USD Million (2023-2028)
  • Table 212. Canada Dong Quai , by Application USD Million (2023-2028)
  • Table 213. Canada Dong Quai , by End User USD Million (2023-2028)
  • Table 214. Mexico Dong Quai , by Type USD Million (2023-2028)
  • Table 215. Mexico Dong Quai , by Application USD Million (2023-2028)
  • Table 216. Mexico Dong Quai , by End User USD Million (2023-2028)
  • Table 217. Dong Quai : by Type(USD/Units)
  • Table 218. Research Programs/Design for This Report
  • Table 219. Key Data Information from Secondary Sources
  • Table 220. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dong Quai : by Type USD Million (2017-2022)
  • Figure 5. Global Dong Quai : by Application USD Million (2017-2022)
  • Figure 6. Global Dong Quai : by End User USD Million (2017-2022)
  • Figure 7. South America Dong Quai  Share (%), by Country
  • Figure 8. Asia Pacific Dong Quai  Share (%), by Country
  • Figure 9. Europe Dong Quai  Share (%), by Country
  • Figure 10. MEA Dong Quai  Share (%), by Country
  • Figure 11. North America Dong Quai  Share (%), by Country
  • Figure 12. Global Dong Quai : by Type USD/Units (2017-2022)
  • Figure 13. Global Dong Quai  share by Players 2022 (%)
  • Figure 14. Global Dong Quai  share by Players (Top 3) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Amax NutraSource, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Amax NutraSource, Inc. (United States) Revenue: by Geography 2022
  • Figure 18. Bio Botanica, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bio Botanica, Inc. (United States) Revenue: by Geography 2022
  • Figure 20. Carrubba Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Carrubba Inc. (United States) Revenue: by Geography 2022
  • Figure 22. Organic Herb Inc. (China) Revenue, Net Income and Gross profit
  • Figure 23. Organic Herb Inc. (China) Revenue: by Geography 2022
  • Figure 24. Naturex Group (France) Revenue, Net Income and Gross profit
  • Figure 25. Naturex Group (France) Revenue: by Geography 2022
  • Figure 26. Xian Yuensun Biological Technology Co. Ltd.( United States) Revenue, Net Income and Gross profit
  • Figure 27. Xian Yuensun Biological Technology Co. Ltd.( United States) Revenue: by Geography 2022
  • Figure 28. Symrise Inc.( Germany) Revenue, Net Income and Gross profit
  • Figure 29. Symrise Inc.( Germany) Revenue: by Geography 2022
  • Figure 30. Global Dong Quai : by Type USD Million (2023-2028)
  • Figure 31. Global Dong Quai : by Application USD Million (2023-2028)
  • Figure 32. Global Dong Quai : by End User USD Million (2023-2028)
  • Figure 33. South America Dong Quai  Share (%), by Country
  • Figure 34. Asia Pacific Dong Quai  Share (%), by Country
  • Figure 35. Europe Dong Quai  Share (%), by Country
  • Figure 36. MEA Dong Quai  Share (%), by Country
  • Figure 37. North America Dong Quai  Share (%), by Country
  • Figure 38. Global Dong Quai : by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Amax NutraSource, Inc. (United States)
  • Bio Botanica, Inc. (United States)
  • Carrubba Inc. (United States)
  • Organic Herb Inc. (China)
  • Naturex Group (France)
  • Xian Yuensun Biological Technology Co. Ltd.( United States)
  • Symrise Inc.( Germany)
Select User Access Type

Key Highlights of Report


Dec 2023 207 Pages 78 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dong Quai  Market Quantitative research analysis
Global Dong Quai  Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Amax NutraSource, Inc. (United States), Bio Botanica, Inc. (United States), Carrubba Inc. (United States), Organic Herb Inc. (China), Naturex Group (France), Xian Yuensun Biological Technology Co. Ltd.( United States) and Symrise Inc.( Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Emerging demand for organic treatments" is seen as one of major influencing trends for Dong Quai  Market during projected period 2022-2028.
The Dong Quai  market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dong Quai  Market Report?

Have a Query? Click Here

Other Related Reports

Thiamazole Comprehensive Study by Application (Adults, Children), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Thyroid Hormones Type (T3, T4), Strength (5 mg, 10 ...
$ 3500
Rectocele Treatment Comprehensive Study by Treatment (Surgical (Rectocele Repair Surgery), Non-Surgical (Floor Exercise, Pessary)), Diagnosis (Physical Test, Defecography, Imaging tests, Other tests)...
$ 3450
Calcitonin Salmon Comprehensive Study by Application (Osteoporosis, Paget's Disease, Hypercalcemia), Route of Administration (Injection, Nasal Spray), Distribution Channel (Hospital Pharmacies, Retai...
$ 3350
Dihydrocodeine Comprehensive Study by Application (Cough Suppressant, Analgesic), Route of Administration (Oral, Injection) Players and Region - Global Market Outlook to 2028
$ 3500
Amitryptyline Comprehensive Study by Patient Type (Adult, Pediatric), By Strength (10 mg tablets, 25 mg tablets, 50 mg tablets, 75 mg tablets, 100 mg tablets, 150 mg tablets), Distribution Channel (H...
$ 3650
Sultamicillin Comprehensive Study by Type (Patent, Generic), Application (Complicated Urinary Tract Infection (CUTI), Complicated Intra-Abdominal Infections (CIAI), Blood Stream Infections (BSI), Clo...
$ 3750